Eliminating paper drug labeling such as package inserts in favor of e-labels
could compromise the availability of information for some patients, physicians,
and pharmacists, a government study found.
Stakeholders provided no consensus on the advantages or disadvantages of
relying on drug labeling available only electronically, the Government Accountability Office (GAO) said in a report
Monday.Drug manufacturers have supported eliminating paper labels, whereas patient advocates suggest it could adversely affect public health.
